201 related articles for article (PubMed ID: 32663513)
1. The role of Nrf2 in acute kidney injury: Novel molecular mechanisms and therapeutic approaches.
Wei W; Ma N; Fan X; Yu Q; Ci X
Free Radic Biol Med; 2020 Oct; 158():1-12. PubMed ID: 32663513
[TBL] [Abstract][Full Text] [Related]
2. Toxico-pharmacological perspective of the Nrf2-Keap1 defense system against oxidative stress in kidney diseases.
Saito H
Biochem Pharmacol; 2013 Apr; 85(7):865-72. PubMed ID: 23333765
[TBL] [Abstract][Full Text] [Related]
3. Targeting the KEAP1-NRF2 System to Prevent Kidney Disease Progression.
Nezu M; Suzuki N; Yamamoto M
Am J Nephrol; 2017; 45(6):473-483. PubMed ID: 28502971
[TBL] [Abstract][Full Text] [Related]
4. Targeting Nrf2 in Protection Against Renal Disease.
Guerrero-Hue M; Farre-Alins V; Palomino-Antolin A; Parada E; Rubio-Navarro A; Egido J; Egea J; Moreno JA
Curr Med Chem; 2017; 24(33):3583-3605. PubMed ID: 28494744
[TBL] [Abstract][Full Text] [Related]
5. Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease.
Ruiz S; Pergola PE; Zager RA; Vaziri ND
Kidney Int; 2013 Jun; 83(6):1029-41. PubMed ID: 23325084
[TBL] [Abstract][Full Text] [Related]
6. Poricoic acid A enhances melatonin inhibition of AKI-to-CKD transition by regulating Gas6/AxlNFκB/Nrf2 axis.
Chen DQ; Feng YL; Chen L; Liu JR; Wang M; Vaziri ND; Zhao YY
Free Radic Biol Med; 2019 Apr; 134():484-497. PubMed ID: 30716432
[TBL] [Abstract][Full Text] [Related]
7. Effect of redox modulating NRF2 activators on chronic kidney disease.
Choi BH; Kang KS; Kwak MK
Molecules; 2014 Aug; 19(8):12727-59. PubMed ID: 25140450
[TBL] [Abstract][Full Text] [Related]
8. GSK3β-mediated Keap1-independent regulation of Nrf2 antioxidant response: A molecular rheostat of acute kidney injury to chronic kidney disease transition.
Lu M; Wang P; Qiao Y; Jiang C; Ge Y; Flickinger B; Malhotra DK; Dworkin LD; Liu Z; Gong R
Redox Biol; 2019 Sep; 26():101275. PubMed ID: 31349118
[TBL] [Abstract][Full Text] [Related]
9. Molecular Interactions Between Reactive Oxygen Species and Autophagy in Kidney Disease.
Kaushal GP; Chandrashekar K; Juncos LA
Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31382550
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous Elimination of Reactive Oxygen Species and Activation of Nrf2 by Ultrasmall Nanoparticles to Relieve Acute Kidney Injury.
Bao B; Liu H; Han Y; Xu L; Xing W; Li Z
ACS Appl Mater Interfaces; 2023 Apr; 15(13):16460-16470. PubMed ID: 36946292
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-140-5p attenuated oxidative stress in Cisplatin induced acute kidney injury by activating Nrf2/ARE pathway through a Keap1-independent mechanism.
Liao W; Fu Z; Zou Y; Wen D; Ma H; Zhou F; Chen Y; Zhang M; Zhang W
Exp Cell Res; 2017 Nov; 360(2):292-302. PubMed ID: 28928081
[TBL] [Abstract][Full Text] [Related]
12. Transcription factor Nrf2 hyperactivation in early-phase renal ischemia-reperfusion injury prevents tubular damage progression.
Nezu M; Souma T; Yu L; Suzuki T; Saigusa D; Ito S; Suzuki N; Yamamoto M
Kidney Int; 2017 Feb; 91(2):387-401. PubMed ID: 27789056
[TBL] [Abstract][Full Text] [Related]
13. The protective role of Nrf2 against aristolochic acid-induced renal tubular epithelial cell injury.
Huang X; Wu J; Liu X; Wu H; Fan J; Yang X
Toxicol Mech Methods; 2020 Oct; 30(8):580-589. PubMed ID: 32660364
[TBL] [Abstract][Full Text] [Related]
14. The synthetic triterpenoid RTA dh404 (CDDO-dhTFEA) restores endothelial function impaired by reduced Nrf2 activity in chronic kidney disease.
Aminzadeh MA; Reisman SA; Vaziri ND; Shelkovnikov S; Farzaneh SH; Khazaeli M; Meyer CJ
Redox Biol; 2013; 1(1):527-31. PubMed ID: 24363993
[TBL] [Abstract][Full Text] [Related]
15. 5-Aminolevulinic acid exerts renoprotective effect via Nrf2 activation in murine rhabdomyolysis-induced acute kidney injury.
Uchida A; Kidokoro K; Sogawa Y; Itano S; Nagasu H; Satoh M; Sasaki T; Kashihara N
Nephrology (Carlton); 2019 Jan; 24(1):28-38. PubMed ID: 29068550
[TBL] [Abstract][Full Text] [Related]
16. Filtering through the role of NRF2 in kidney disease.
Schmidlin CJ; Dodson MB; Zhang DD
Arch Pharm Res; 2020 Mar; 43(3):361-369. PubMed ID: 31372933
[TBL] [Abstract][Full Text] [Related]
17. Renoprotective mechanisms of Astragaloside IV in cisplatin-induced acute kidney injury.
Yan W; Xu Y; Yuan Y; Tian L; Wang Q; Xie Y; Shao X; Zhang M; Ni Z; Mou S
Free Radic Res; 2017; 51(7-8):669-683. PubMed ID: 28750561
[TBL] [Abstract][Full Text] [Related]
18. The Role of Mitochondria in Acute Kidney Injury and Chronic Kidney Disease and Its Therapeutic Potential.
Zhang X; Agborbesong E; Li X
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681922
[TBL] [Abstract][Full Text] [Related]
19. Nrf2 deficiency induces oxidative stress and promotes RANKL-induced osteoclast differentiation.
Hyeon S; Lee H; Yang Y; Jeong W
Free Radic Biol Med; 2013 Dec; 65():789-799. PubMed ID: 23954472
[TBL] [Abstract][Full Text] [Related]
20. p62/SQSTM1 protects against cisplatin-induced oxidative stress in kidneys by mediating the cross talk between autophagy and the Keap1-Nrf2 signalling pathway.
Liao W; Wang Z; Fu Z; Ma H; Jiang M; Xu A; Zhang W
Free Radic Res; 2019 Jul; 53(7):800-814. PubMed ID: 31223046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
